Parkinson’s Disease Awareness Month.
Fiscal committee
No
Current location
Chaptered
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed Assembly
- Passed Senate
- To Governor
- Became Law
Overview
This resolution designates April 2026 as Parkinson’s Disease Awareness Month in California. It acknowledges the significant impact of Parkinson’s disease on individuals, families, and the state’s healthcare system, citing its prevalence, associated costs, and ongoing research efforts. The resolution highlights advancements in disease understanding, such as biomarker validation and the California Neurodegenerative Disease Registry, and emphasizes the need for continued investment in research and care.
Key provisions
- Proclaims April 2026 as Parkinson’s Disease Awareness Month in California.
- Recognizes the prevalence and impact of Parkinson’s disease in the state.
- Acknowledges advancements in Parkinson’s disease research, including biomarker validation.
- References the California Parkinson’s Disease Registry and its role in data collection.
- Highlights the importance of ongoing research and investment in the field.
- Mentions the Michael J. Fox Foundation’s Parkinson’s Progression Markers Initiative (PPMI).
- References California’s efforts to evaluate pesticide exposure and neurological health.
- Recognizes the contributions of caregivers, researchers, and medical professionals.
Who is affected
- Individuals with Parkinson’s disease and their families
- Caregivers and friends of individuals with Parkinson’s disease
- Healthcare providers and medical professionals
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
71 on record
Primary sponsor
Cosponsors
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours